INS and Hypoglycemia: Since TIR (% of time spent with glucose 70–180 mg/dL) is increasingly recognized as a robust indicator of glycemic control, closely linked to microvascular complications and complementary to HbA1c, these findings suggest that weekly insulin may offer superior day‐to‐day stability without additional hypoglycemia risk [49, 50].